Evidence map›Paper›PMID 33498217›Full record

ArticleDiagnostics (Basel, Switzerland)2021

DGEMRIC in the Assessment of Pre-Morphological Cartilage Degeneration in Rheumatic Disease: Rheumatoid Arthritis vs. Psoriatic Arthritis.

Daniel B Abrar, Christoph Schleich, Miriam Frenken, Stefan Vordenbäumen, Jutta Richter, Matthias Schneider, Benedikt Ostendorf, Sven Nebelung, Philipp Sewerin

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Imaging update in inflammatory arthritis.Journal of clinical orthopaedics and trauma · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel B AbrarMedical Faculty, Department of Diagnostic and Interventional Radiology, University Dusseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-8116-4431
Christoph SchleichMedical Faculty, Department of Diagnostic and Interventional Radiology, University Dusseldorf, 40225 Düsseldorf, Germany.
Miriam FrenkenMedical Faculty, Department of Diagnostic and Interventional Radiology, University Dusseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0001-5197-6861
Stefan VordenbäumenDepartment and Hiller Research Unit for Rheumatology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Jutta RichterDepartment and Hiller Research Unit for Rheumatology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Matthias SchneiderDepartment and Hiller Research Unit for Rheumatology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Benedikt OstendorfDepartment and Hiller Research Unit for Rheumatology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Sven NebelungMedical Faculty, Department of Diagnostic and Interventional Radiology, University Dusseldorf, 40225 Düsseldorf, Germany.ORCID 0000-0002-5267-9962
Philipp SewerinDepartment and Hiller Research Unit for Rheumatology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.ORCID 0000-0001-8465-6207

Funding

Abbvie Deutschlang Delayed Gadolinium-enhanced MR Imaging of Cartilage - A pilot study to measure the effect of Adalimumab plus MTX versus Placebo plus MTX on cartilage in early RA patients (CAR-ERA) StudyBundesministerium für Bildung und Forschung 01EC1009Deutsche Forschungsgemeinschaft DFG, NE 2136/3-1Medizinische Fakultät, Heinrich Heine Universität Düsseldorf Clinician Scientist Program Stufe 1Pfizer Germany Pfizer GIP Inflammation Germany Research Initiative
6 · The paper itself

Abstract

backgroundEven though cartilage loss is a known feature of psoriatic (PsA) and rheumatoid arthritis (RA), research is sparse on its role in the pathogenesis of PsA, its potential use for disease monitoring and for differentiation from RA. We therefore assessed the use of delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) to evaluate biochemical cartilage changes in metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints in PsA patients and compared these to RA patients. MATERIALS AND

methodsA total of 17 patients with active PsA and 20 patients with active RA were evaluated by high-resolution 3 Tesla dGEMRIC using a dedicated 16-channel hand coil. Images were analyzed by two independent raters for dGEMRIC indices and joint space width (JSW) at MCP and PIP joint levels.

resultsNo significant differences of dGEMRIC values could be found between both study populations (PsA 472.25 ms, RA 461.11 ms;

conclusionsAs evaluated by dGEMRIC, the molecular composition of the MCP and PIP joint cartilage of PsA patients is similar to that of RA patients, demonstrating the scientific and clinical feasibility of compositional magnetic resonance (MR) imaging in these disease entities. Patterns and severity of compositional cartilage degradation of the finger joints may therefore be assessed beyond mere morphology in PsA and RA patients.

Indexed as

cartilagecompositional imagingdGEMRICmagnetic resonance imagingpsoriatic arthritisrheumatoid arthritis

Identifiers

PMID33498217
PMCPMC7908973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.